Panel Tells F.D.A. That CRISPR Sickle Cell Cure Is Safe Enough for Patients
A panel of experts said on Tuesday that a groundbreaking treatment for sickle cell disease was safe enough for clinical use, setting the stage for likely federal approval by Dec.…